EFFECT OF UGT2B7 G211T MUTANT ON MYCOPHENOLATE MOFETIL METABOLITES PHARMACOKINETICS IN HEALTHY SUBJECTS

被引：0
|
作者：
Yi, Juan [1 ]
Tan, Zhi-Rong [1 ]
Chen, Rao [1 ]
Li, Qing [1 ]
Zhang, Wei [1 ]
Guo, Dong [1 ]
Pei, Fang [1 ]
Zhou, Hong-Hao [1 ]
机构：
[1] Cent S Univ, Inst Clinincal Pharmacol, Changsha, Hunan, Peoples R China
来源：
DRUG METABOLISM REVIEWS | 2008年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
61
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [1] UGT2B7 haplotypes but not MRP2 genetic variations are associated with pharmacokinetic variations of mycophenolate mofetil in healthy subjects.
    Benoit-Biancamano, M.
    Levesque, E.
    Delage, R.
    Couture, F.
    Guillemette, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S31 - S32
  • [2] EFFECT OF UGT2B7 POLYMORPHISMS ON GEMFIBROZIL PHARMACOKINETICS IN HEALTHY VOLUNTEERS.
    Rower, J. E.
    Hammond, K. P.
    Torres, R. C.
    Bushman, L. R.
    Hopley, C. W.
    Daily, E. B.
    Sidhom, M. S.
    Miller, W.
    Predhomme, J. A.
    Kosmiski, L. A.
    Aquilante, C. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S44 - S45
  • [3] The Effect of UGT2B7*2 Polymorphism on the Pharmacokinetics of OROS® Hydromorphone in Taiwanese Subjects
    Vandenbossche, Joris
    Richards, Henry
    Francke, Stephan
    Van Den Bergh, An
    Lu, Chih Cherng
    Franc, Monique A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (10): : 1170 - 1179
  • [4] UGT2B7 C802T和G211T基因多态性对癫痫患者丙戊酸代谢的影响
    孙银香
    卓文燕
    林虹
    彭正科
    王化明
    黄好武
    罗玉鸿
    唐发清
    中国医院药学杂志, 2015, 35 (03) : 216 - 219
  • [5] UGT1A9 C-2152T和UGT2B7 G211T突变在中国汉族人群中的分布
    易娟
    谢海棠
    周宏灏
    中国临床药理学与治疗学, 2007, (04) : 460 - 464
  • [6] Association between Food/UGT2B7 Polymorphisms and Pharmacokinetics/Pharmacodynamics Properties of Indapamide in Healthy Humans
    Abbas, Banaz
    Sabri, Nagwa A.
    El-Khouly, Amal A.
    BIOMEDICINES, 2023, 11 (05)
  • [7] Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects
    Saito, K
    Moriya, H
    Sawaguchi, T
    Hayakawa, T
    Nakahara, S
    Goto, A
    Arimura, Y
    Imai, K
    Kurosawa, N
    Owada, E
    Miyamoto, A
    CLINICAL BIOCHEMISTRY, 2006, 39 (03) : 303 - 308
  • [8] UGT2B7*3 did not affect the pharmacokinetics of R- and S-carvedilol in healthy Japanese
    Honda, Mutsuko
    Toyoda, Wakako
    Shimizu, Takako
    Horiuchi, Isao
    Kayano, Yuichiro
    Taguchi, Masato
    Nozawa, Takashi
    Inoue, Hiroshi
    Hashimoto, Yukiya
    DRUG METABOLISM AND PHARMACOKINETICS, 2007, 22 (05) : 382 - 386
  • [9] Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects
    Chung, J-Y
    Cho, J-Y
    Yu, K-S
    Kim, J-R
    Lim, K. S.
    Sohn, D-R
    Shin, S-G
    Jang, I-J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (04) : 595 - 600
  • [10] Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients
    Noppaket Singkham
    Somchai Towanabut
    Surang Lertkachatarn
    Baralee Punyawudho
    European Journal of Clinical Pharmacology, 2013, 69 : 1285 - 1291
12345